Table 5 Whole-body bone SPECT/CT detection rates according to pre-test PSA classes
PSA class | Bone metastatic patient N (%) |
|---|---|
> 10 ng/mL | 14/28 (50%) |
2–10 ng/mL | 11/65 (17%) |
1–2 ng/mL | 1/12 (8%) |
< 1 ng/mL | 1/10 (10%) |
Total | 27/115 (23%) |
PSA class | Bone metastatic patient N (%) |
|---|---|
> 10 ng/mL | 14/28 (50%) |
2–10 ng/mL | 11/65 (17%) |
1–2 ng/mL | 1/12 (8%) |
< 1 ng/mL | 1/10 (10%) |
Total | 27/115 (23%) |